Cresco Labs Inc.
CL
CNSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.26% | -1.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.26% | -1.50% | |||
| Cost of Revenue | 6.41% | -3.61% | |||
| Gross Profit | -10.39% | 0.56% | |||
| SG&A Expenses | -4.18% | 7.91% | |||
| Depreciation & Amortization | -4.30% | 9.89% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.92% | 1.02% | |||
| Operating Income | -24.13% | -12.87% | |||
| Income Before Tax | -73.02% | 127.65% | |||
| Income Tax Expenses | -86.24% | 85.74% | |||
| Earnings from Continuing Operations | 105.71% | 84.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -68.98% | 9.71% | |||
| Net Income | 58.52% | 80.60% | |||
| EBIT | -24.13% | -12.87% | |||
| EBITDA | -18.22% | -8.85% | |||
| EPS Basic | 58.42% | 80.76% | |||
| Normalized Basic EPS | -141.88% | 119.05% | |||
| EPS Diluted | 58.42% | 80.76% | |||
| Normalized Diluted EPS | -141.88% | 119.05% | |||
| Average Basic Shares Outstanding | 0.17% | 0.70% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||